ES2187056T3 - Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo. - Google Patents

Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo.

Info

Publication number
ES2187056T3
ES2187056T3 ES98941526T ES98941526T ES2187056T3 ES 2187056 T3 ES2187056 T3 ES 2187056T3 ES 98941526 T ES98941526 T ES 98941526T ES 98941526 T ES98941526 T ES 98941526T ES 2187056 T3 ES2187056 T3 ES 2187056T3
Authority
ES
Spain
Prior art keywords
product
derivative
uracilo
bicatenary
bencil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98941526T
Other languages
English (en)
Inventor
Eric Ruhlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of ES2187056T3 publication Critical patent/ES2187056T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a un producto que comprende al menos un ARN de doble hebra combinado con al menos un derivado de 6-benciluracilo para una utilización terapéutica simultánea, separada o extendida en el tiempo. Dicho producto se puede combinar opcionalmente con otro agente antiviral. Dichos productos son particularmente útiles para tratar el SIDA (Síndrome de Inmunodeficiencia Adquirida).
ES98941526T 1997-08-04 1998-08-03 Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo. Expired - Lifetime ES2187056T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709974A FR2766711B1 (fr) 1997-08-04 1997-08-04 Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps

Publications (1)

Publication Number Publication Date
ES2187056T3 true ES2187056T3 (es) 2003-05-16

Family

ID=9510012

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98941526T Expired - Lifetime ES2187056T3 (es) 1997-08-04 1998-08-03 Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo.

Country Status (10)

Country Link
EP (1) EP1001789B1 (es)
AT (1) ATE227132T1 (es)
AU (1) AU8987198A (es)
DE (1) DE69809246T2 (es)
DK (1) DK1001789T3 (es)
ES (1) ES2187056T3 (es)
FR (1) FR2766711B1 (es)
NO (1) NO20000554D0 (es)
PT (1) PT1001789E (es)
WO (1) WO1999007384A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
EP1001789A1 (fr) 2000-05-24
DE69809246D1 (de) 2002-12-12
NO20000554L (no) 2000-02-03
EP1001789B1 (fr) 2002-11-06
NO20000554D0 (no) 2000-02-03
FR2766711A1 (fr) 1999-02-05
PT1001789E (pt) 2003-03-31
AU8987198A (en) 1999-03-01
FR2766711B1 (fr) 2001-02-02
WO1999007384A1 (fr) 1999-02-18
ATE227132T1 (de) 2002-11-15
DE69809246T2 (de) 2003-08-28
DK1001789T3 (da) 2003-03-10

Similar Documents

Publication Publication Date Title
ES2171039T3 (es) Producto que comprende al menos un rna bicatenario en asociacion con al menos un interferon para el tratamiento de la hepatitis viral.
NO985643L (no) Antimikrobielle blandinger
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
ES2157422T3 (es) Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
MY138883A (en) Use of asiatic acid for treatment of cencer
DE59902006D1 (de) Wirkstoffhaltige aromatische copolyester
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
NZ524936A (en) Methods of inducing cancer cell death and tumor regression using a FTP inhibitor and a tyrosine kinase inhibitor
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU2672099A (en) Compositions and methods for wound healing
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ES2187056T3 (es) Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo.
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse